Financhill
Sell
35

PLRX Quote, Financials, Valuation and Earnings

Last price:
$13.57
Seasonality move :
6.8%
Day range:
$13.48 - $14.23
52-week range:
$10.22 - $19.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
168.30x
P/B ratio:
2.47x
Volume:
359.9K
Avg. volume:
627.9K
1-year change:
-29.19%
Market cap:
$853.8M
Revenue:
$1.6M
EPS (TTM):
-$3.34

Earnings Data

Next earnings date for PLRX
Feb 27
2025
Most recent earnings per share
-$0.95
Beat by $0.03
(Nov 7/2024)
Consensus Estimate
-$0.98
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PLRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $83.3K -- -- -$0.98 --
11/07/2024 Q3 $354.2K -- -$0.95 -$0.98 $0.03
08/07/2024 Q2 $399.6K -- -$0.92 -$0.85 -$0.07
05/06/2024 Q1 $387.1K -- -$0.78 -$0.77 -$0.01
02/27/2024 Q4 $458.3K -- -$0.69 -$0.82 $0.13
11/09/2023 Q3 -- -- -$0.70 -$0.77 $0.07
08/09/2023 Q2 -- -- -$0.70 -$0.69 -$0.01
05/09/2023 Q1 -- -- -$0.67 -$0.67 --
03/09/2023 Q4 -- -- -$0.72 -$0.70 -$0.02
11/08/2022 Q3 -- -- -$0.65 -$0.74 $0.09
08/08/2022 Q2 -- -- -$0.82 -$0.81 -$0.01
05/09/2022 Q1 -- -- -$0.78 -$0.74 -$0.04
02/28/2022 Q4 -- -- -$0.68 -$0.75 $0.07
11/09/2021 Q3 -- -- -$0.75 -$0.69 -$0.06
08/09/2021 Q2 -- -- -$0.64 -$0.67 $0.03
05/10/2021 Q1 -- -- -$0.64 -$0.60 -$0.04
03/16/2021 Q4 -- -- -$0.54 -$0.60 $0.06
11/10/2020 Q3 -- -- -$0.47 -$0.60 $0.13
08/11/2020 Q2 -- -- -$1.39 -$0.68 -$0.71
03/31/2020 Q1 -- -- -- -- --
12/31/2019 Q4 -- -- $1.75 -- --
09/30/2019 Q3 -- -- -$0.67 -- --
06/30/2019 Q2 -- -- -$0.77 -- --
03/31/2019 Q1 -- -- -$0.70 -- --

Pliant Therapeutics Earnings Questions

  • How Much did Pliant Therapeutics Generate in Revenue Last Quarter?

    Pliant Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Pliant Therapeutics Beat Earnings Last Quarter?

    Pliant Therapeutics announced earnings per share of -$0.95 which represents a beat of analyst forecast a -$0.98 per share.

  • Is Pliant Therapeutics Profitable?

    Pliant Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Pliant Therapeutics EPS Next Year?

    Pliant Therapeutics's earnings are forecast to decrease from -$2.75 per share to -$2.89 per share next year representing a decrease of -31.97%.

  • When is Pliant Therapeutics's Earnings Date?

    Pliant Therapeutics's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock